Clindamycin/tretinoin - Stiefel Laboratories
At a glance
- Drug Originator Astellas Pharma BV
- Drug Licenced by Almirall S.A.; Aqua Pharmaceuticals; Stiefel Laboratories
- Drug Class Antiacnes; Antibacterials; Keratolytics; Lincosamides; Retinoids; Small molecules
- Mechanism of Action Protein 50S ribosomal subunit inhibitors; Protein synthesis inhibitors; Retinoic acid receptor agonists
- USA Patent Applicants ALMIRALL
- USA Patents 2
- NDAs 1
Table of Contents
Disclaimer